Juva Life Stock Net Asset
| JUVAF Stock | USD 0.0001 0.00 0.00% |
Juva Life fundamentals help investors to digest information that contributes to Juva Life's financial success or failures. It also enables traders to predict the movement of Juva OTC Stock. The fundamental analysis module provides a way to measure Juva Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Juva Life otc stock.
Juva |
Juva Life OTC Stock Net Asset Analysis
Juva Life's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
| Competition |
Based on the recorded statements, Juva Life has a Net Asset of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Juva Net Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Juva Life's direct or indirect competition against its Net Asset to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Juva Life could also be used in its relative valuation, which is a method of valuing Juva Life by comparing valuation metrics of similar companies.Juva Life is currently under evaluation in net asset category among its peers.
Juva Fundamentals
| Return On Equity | -1.19 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (1.70) % | |||
| Operating Margin | (1.65) % | |||
| Current Valuation | 23.45 M | |||
| Shares Outstanding | 164.02 M | |||
| Shares Owned By Insiders | 31.70 % | |||
| Price To Book | 1.91 X | |||
| Price To Sales | 2.72 X | |||
| Revenue | 5.55 M | |||
| Gross Profit | 795.94 K | |||
| EBITDA | (9.17 M) | |||
| Net Income | (11.36 M) | |||
| Cash And Equivalents | 5.19 M | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 353.93 K | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 2.78 X | |||
| Book Value Per Share | 0.05 X | |||
| Cash Flow From Operations | (8.79 M) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | 0.99 | |||
| Market Capitalization | 14.76 M | |||
| Z Score | 24.6 |
About Juva Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Juva Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Juva Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Juva Life based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Juva OTC Stock
Juva Life financial ratios help investors to determine whether Juva OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Juva with respect to the benefits of owning Juva Life security.